Parabilis Medicines, Inc. (PBLS)
NASDAQ · Pharmaceuticals & Biotech · Pharmaceutical Preparations
- Price
- $36.93
- Day
- -11.50%
- Market cap
- $1.07B
Close 2026-09-21.
Institutional holders
Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.
- RA CAPITAL MANAGEMENT, L.P. — $791.91M
- FMR LLC — $183.48M
- ARCH Venture Management, LLC — $175.52M
- venBio Partners LLC — $144.15M
- Alphabet Inc. — $134.65M
- Nextech Invest Ltd. — $127.63M
- Cormorant Asset Management, LP — $126.33M
- REGENERON PHARMACEUTICALS, INC. — $114.04M
Insider trades
Open-market buys and sales filed on Form 4, newest first. Grants, option exercises and tax withholding are left out.
- RA CAPITAL MANAGEMENT, L.P. (Director,TenPercentOwner) bought 47,250 shares at $29.77 on 2026-07-22
- RA CAPITAL MANAGEMENT, L.P. (Director,TenPercentOwner) bought 21,696 shares at $27.96 on 2026-07-21
- RA CAPITAL MANAGEMENT, L.P. (Director,TenPercentOwner) bought 6,504 shares at $29.17 on 2026-07-21
- RA CAPITAL MANAGEMENT, L.P. (Director,TenPercentOwner) bought 37,723 shares at $30.00 on 2026-07-21
- RA CAPITAL MANAGEMENT, L.P. (Director,TenPercentOwner) bought 98,433 shares at $27.13 on 2026-07-20
- RA CAPITAL MANAGEMENT, L.P. (Director,TenPercentOwner) bought 32,987 shares at $27.72 on 2026-07-20
Recent filings
- 8-K — 2026-09-15
- 8-K — 2026-09-02
- 3 — 2026-08-25
- 4 — 2026-08-25
- 8-K — 2026-08-25
- SCHEDULE 13G — 2026-08-14
- 10-Q — 2026-08-13
- 8-K — 2026-08-13
- SCHEDULE 13G — 2026-08-06
- 4 — 2026-07-22